These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 20117197)

  • 81. NSAIDs and aspirin: friends or foes?
    Berenbaum F
    Joint Bone Spine; 2003 Mar; 70(2):89-90. PubMed ID: 12713849
    [No Abstract]   [Full Text] [Related]  

  • 82. Effect of temperature and fat content on the solubility of hydrochlorothiazide and chlorothiazide in milk.
    Macheras PE; Koupparis MA; Antimisiaris SG
    J Pharm Sci; 1989 Nov; 78(11):933-6. PubMed ID: 2621578
    [TBL] [Abstract][Full Text] [Related]  

  • 83. All topical NSAIDs not created equal--understanding topical analgesic drug formulations.
    Galer BS
    Pain; 2008 Sep; 139(1):237-238. PubMed ID: 18760535
    [No Abstract]   [Full Text] [Related]  

  • 84. Drug binding and solubility in milk.
    Macheras PE; Koupparis MA; Antimisiaris SG
    Pharm Res; 1990 May; 7(5):537-41. PubMed ID: 1694991
    [TBL] [Abstract][Full Text] [Related]  

  • 85. The pharmacokinetics of aspirin in rats and the effect of buffer.
    Fu CJ; Melethil S; Mason WD
    J Pharmacokinet Biopharm; 1991 Apr; 19(2):157-73. PubMed ID: 2013838
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Enhanced NSAIDs Solubility in Drug-Drug Formulations with Ciprofloxacin.
    Acebedo-Martínez FJ; Domínguez-Martín A; Alarcón-Payer C; Sevillano-Páez A; Verdugo-Escamilla C; González-Pérez JM; Martínez-Checa F; Choquesillo-Lazarte D
    Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36834716
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Effects of food on pharmacokinetics of immediate release oral formulations.
    Heintze K; Fuchs W
    Br J Clin Pharmacol; 2015 Nov; 80(5):1239. PubMed ID: 26140311
    [No Abstract]   [Full Text] [Related]  

  • 88. Reply to 'Effects of food on pharmacokinetics of immediate release oral formulations'.
    Moore RA; Derry S; Wiffen PJ; Straube S
    Br J Clin Pharmacol; 2015 Nov; 80(5):1238. PubMed ID: 26138369
    [No Abstract]   [Full Text] [Related]  

  • 89. Therapeutic Liquid Formulations Based on Low Transition Temperature Mixtures for the Incorporation of Anti-Inflammatory Drugs.
    Roda A; Paiva A; Duarte ARC
    Pharmaceutics; 2021 Oct; 13(10):. PubMed ID: 34683913
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Solubility Study of Acetylsalicylic Acid in Ethanol + Water Mixtures: Measurement, Mathematical Modeling, and Stability Discussion.
    Nokhodchi A; Ghafourian T; Nashed N; Asare-Addo K; Behboudi E; Sefid-Sefidehkhan Y; Zarghampour A; Rahimpour E; Jouyban A
    AAPS PharmSciTech; 2021 Dec; 23(1):42. PubMed ID: 34964076
    [TBL] [Abstract][Full Text] [Related]  

  • 91. [HPLC-method for deliberation of drug mammary transfer-evaluation of over-the-counter drugs (Loxonin(®)-S, Bufferin(®) A) in mother mice].
    Komori K; Komae R; Yamazaki Y; Nakano S; Mitamura S; Miyazaki T; Kikuta M; Takada M; Shuto M; Hane Y; Yamamoto T
    Yakugaku Zasshi; 2013; 133(8):905-11. PubMed ID: 23903231
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Effects of food on pharmacokinetics of immediate release oral formulations of simple analgesics: potential implications for drug use, safety and efficacy.
    Hilmer SN; MacPherson R
    Br J Clin Pharmacol; 2015 Dec; 80(6):1243-4. PubMed ID: 26264792
    [No Abstract]   [Full Text] [Related]  

  • 93. Combining aspirin with other NSAIDs.
    McGuffey EC; Roberts P
    Am Pharm; 1994 May; NS34(5):22. PubMed ID: 8037114
    [No Abstract]   [Full Text] [Related]  

  • 94. Oral cyclosporine A--the current picture of its liposomal and other delivery systems.
    Czogalla A
    Cell Mol Biol Lett; 2009; 14(1):139-52. PubMed ID: 19005620
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Metformin-NSAIDs Molecular Salts: A Path towards Enhanced Oral Bioavailability and Stability.
    Acebedo-Martínez FJ; Domínguez-Martín A; Alarcón-Payer C; Garcés-Bastida C; Verdugo-Escamilla C; Gómez-Morales J; Choquesillo-Lazarte D
    Pharmaceutics; 2023 Jan; 15(2):. PubMed ID: 36839770
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Discomfort from an alkaline formulation delivered subcutaneously in humans: albumin at pH 7 versus pH 10.
    Ward WK; Castle JR; Branigan DL; Massoud RG; El Youssef J
    Clin Drug Investig; 2012 Jul; 32(7):433-8. PubMed ID: 22568666
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Immunosuppressive drug therapy.
    Dodds WJ
    Can Vet J; 1996 Mar; 37(3):133. PubMed ID: 8681279
    [No Abstract]   [Full Text] [Related]  

  • 98. The Influence of Selected Factors on the Aqueous Cryptotanshinone Solubility.
    Kobryń J; Dałek J; Musiał W
    Pharmaceutics; 2021 Jun; 13(7):. PubMed ID: 34209049
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Evaluation of orally administered highly variable drugs and drug formulations.
    Shah VP; Yacobi A; Barr WH; Benet LZ; Breimer D; Dobrinska MR; Endrenyi L; Fairweather W; Gillespie W; Gonzalez MA; Hooper J; Jackson A; Lesko LJ; Midha KK; Noonan PK; Patnaik R; Williams RL
    Pharm Res; 1996 Nov; 13(11):1590-4. PubMed ID: 8956322
    [No Abstract]   [Full Text] [Related]  

  • 100. A solubility problem in the preparation of uric acid standards.
    McCulloch JC
    Clin Chim Acta; 1978 Mar; 84(1-2):269-71. PubMed ID: 639314
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.